Solvonis Therapeutics plc (LON:SVNS)
London
· Delayed Price · Currency is GBP · Price in GBX 0.224
-0.001 (-0.44%)
Mar 9, 2026, 4:35 PM GMT
Solvonis Therapeutics Balance Sheet
Financials in millions GBP. Fiscal year is January - December.
Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2021 | 2020 - 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | May '21 May 31, 2021 | 2020 - 2018 |
| Cash & Equivalents | 1.72 | 0.76 | 0.16 | 1.64 | 0.6 | 0.04 | Upgrade
|
| Cash & Short-Term Investments | 1.72 | 0.76 | 0.16 | 1.64 | 0.6 | 0.04 | Upgrade
|
| Cash Growth | 6266.67% | 388.39% | -90.55% | 174.25% | 1433.33% | 56.00% | Upgrade
|
| Accounts Receivable | 0.12 | - | 0.07 | 0.04 | 0.02 | 0.04 | Upgrade
|
| Other Receivables | - | 0.04 | 0.02 | 0.06 | 0.12 | 0.04 | Upgrade
|
| Receivables | 0.12 | 0.04 | 0.09 | 0.1 | 0.14 | 0.09 | Upgrade
|
| Inventory | - | - | 0.05 | 0.19 | - | - | Upgrade
|
| Prepaid Expenses | - | 0.02 | 0.02 | 0.23 | - | - | Upgrade
|
| Total Current Assets | 1.83 | 0.82 | 0.31 | 2.16 | 0.74 | 0.13 | Upgrade
|
| Property, Plant & Equipment | - | - | 0.04 | 0.7 | 0.31 | 0.36 | Upgrade
|
| Other Intangible Assets | 7.71 | 2.09 | 2.07 | 2.07 | 2.07 | 2.07 | Upgrade
|
| Other Long-Term Assets | 0 | 0.3 | 0.01 | 0.01 | 0.01 | 0.01 | Upgrade
|
| Total Assets | 9.55 | 3.2 | 2.43 | 4.94 | 3.13 | 2.57 | Upgrade
|
| Accounts Payable | 1.55 | 0.08 | 0.16 | 0.19 | 0.84 | 0.42 | Upgrade
|
| Accrued Expenses | - | 0.04 | 0.09 | 0.14 | 0.52 | 0.22 | Upgrade
|
| Short-Term Debt | 0.08 | - | - | - | 0.96 | 0.65 | Upgrade
|
| Current Portion of Leases | - | - | 0.01 | 0 | - | - | Upgrade
|
| Current Unearned Revenue | - | - | 0.09 | 0.04 | - | - | Upgrade
|
| Other Current Liabilities | 0 | - | 0.03 | - | - | 0.03 | Upgrade
|
| Total Current Liabilities | 1.63 | 0.12 | 0.39 | 0.37 | 2.32 | 1.32 | Upgrade
|
| Long-Term Leases | - | - | 0.02 | 0.02 | - | - | Upgrade
|
| Total Liabilities | 2.61 | 0.12 | 0.41 | 0.39 | 2.32 | 1.32 | Upgrade
|
| Common Stock | 5.85 | 2.23 | 0.04 | 0.04 | 0.01 | 0.01 | Upgrade
|
| Additional Paid-In Capital | 9.14 | 7.36 | 7 | 7 | 0.94 | 0.94 | Upgrade
|
| Retained Earnings | -12.18 | -10.56 | -8.97 | -5.85 | -3.14 | -2.19 | Upgrade
|
| Comprehensive Income & Other | 4.12 | 4.04 | 3.95 | 3.36 | 3 | 2.48 | Upgrade
|
| Shareholders' Equity | 6.94 | 3.08 | 2.03 | 4.55 | 0.81 | 1.25 | Upgrade
|
| Total Liabilities & Equity | 9.55 | 3.2 | 2.43 | 4.94 | 3.13 | 2.57 | Upgrade
|
| Total Debt | 0.08 | - | 0.03 | 0.02 | 0.96 | 0.65 | Upgrade
|
| Net Cash (Debt) | 1.64 | 0.76 | 0.12 | 1.62 | -0.36 | -0.62 | Upgrade
|
| Net Cash Growth | - | 525.62% | -92.52% | - | - | - | Upgrade
|
| Net Cash Per Share | 0.00 | 0.00 | 0.00 | 0.02 | -0.01 | -0.01 | Upgrade
|
| Filing Date Shares Outstanding | 5,909 | 2,296 | 124.76 | 104.1 | 70 | 69 | Upgrade
|
| Total Common Shares Outstanding | 5,909 | 2,296 | 104.1 | 104.1 | 70 | 69 | Upgrade
|
| Working Capital | 0.2 | 0.7 | -0.07 | 1.79 | -1.58 | -1.2 | Upgrade
|
| Book Value Per Share | 0.00 | 0.00 | 0.02 | 0.04 | 0.01 | 0.02 | Upgrade
|
| Tangible Book Value | -0.78 | 1 | -0.04 | 2.49 | -1.26 | -0.82 | Upgrade
|
| Tangible Book Value Per Share | -0.00 | 0.00 | -0.00 | 0.02 | -0.02 | -0.01 | Upgrade
|
| Machinery | - | - | - | 0.94 | 0.54 | 0.55 | Upgrade
|
| Leasehold Improvements | - | - | - | 0.09 | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.